Jichi Medical University / 自治医科大学

LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Journal article Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension (2021) Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder R, Townsend RR, et al. Journal article European Society of Hypertension position paper on renal denervation 2021 (2021) Schmieder R, Mahfoud F, Mancia G, Azizi M, Boehm M, Dimitriadis K, Kario K, et al. Journal article Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation (2021) Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder R, Tsioufis K, Pocock S, et al. Journal article Confounding Factors in Renal Denervation Trials Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension (2020) Kandzari DE, Mahfoud F, Bhatt DL, Boehm M, Weber MA, Townsend RR, Hettrick DA, et al. Journal article, Review article Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial (2020) Mahfoud F, Townsend R, Kandzari D, Kario K, Schmieder R, Tsioufis K, Boehm M, et al. Conference contribution Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial (2020) Kario K, Weber MA, Böhm M, Townsend RR, Mahfoud F, Schmieder R, Tsioufis K, et al. Journal article Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (Clinical Research in Cardiology, (2020), 109, 3, (289-302), 10.1007/s00392-020-01595-z) (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article, Erratum